China's pharmaceutical dominance raises supply chain resilience, quality concerns
New Delhi, Nov 10 (IANS) China's growing dominance in pharmaceutical manufacturing, particularly in active pharmaceutical ingredients (APIs) and critical medical supplies, creates concerns about supply-chain concentration and strategic dependence on a single country, a report has said.